Barriers to care experienced by patients who inject drugs during the COVID-19 pandemic: a qualitative analysis E Gleason, NS Nolan, LR Marks, T Habrock, SY Liang, MJ Durkin Journal of addiction medicine 16 (2), e133-e136, 2022 | 26 | 2022 |
“Parir no es un asunto de etnia, es un asunto de humanidad”: experiencias frente a la violencia obstétrica durante la atención al parto en mujeres indígenas EG Gleason, DPM Berrío, JML Ríos, CMM Merino Salud colectiva 17, e3727, 2021 | 13 | 2021 |
Multistakeholder perspectives on the mistreatment of indigenous women during childbirth in Colombia: drivers and points for intervention EG Gleason, JM López Ríos, DP Molina Berrío, C Mejía Merino BMC Pregnancy and Childbirth 22 (1), 197, 2022 | 5 | 2022 |
Telehealth utilization in gynecologic oncology clinical trials L Andriani, J Oh, E McMinn, E Gleason, NC Koelper, J Chittams, ... Gynecologic Oncology 177, 103-108, 2023 | 3 | 2023 |
Online Learning for Infectious Disease Fellows—A Needs Assessment MA Chavez, NS Nolan, E Gleason, S Nematollahi, E Abdoler, G Escota Open Forum Infectious Diseases 9 (7), ofac264, 2022 | 3 | 2022 |
Post-exposure prophylaxis for human immunodeficiency virus after sexual assault in a Midwestern US emergency department JN Cherabie, E Gleason, S Munigala, B Fox, A Trolard, C McCammon, ... The American Journal of Emergency Medicine 49, 117-123, 2021 | 3 | 2021 |
Cost of care associated with utilization of telehealth in clinical trials. E Gleason, E Tubridy, L Andriani, D Uwawuike, S Gunter, N Koelper, ... Journal of Clinical Oncology 41 (16_suppl), e13682-e13682, 2023 | 1 | 2023 |
Current diagnostic guidelines and perpetuation of inequities in ovarian cancer: A National Cancer Database study. AJB Smith, E Gleason, S Kadiyala, X Wang, EA Howell, AM McCarthy Journal of Clinical Oncology 42 (16_suppl), 11027-11027, 2024 | | 2024 |
Variation in telemedicine usage in gynecologic cancer: Are we widening or narrowing disparities? AJB Smith, EG Gleason, L Andriani, J Heintz, EM Ko Gynecologic Oncology 184, 160-167, 2024 | | 2024 |
Please let us know how this document benefits you. MA Chavez, S Munigala, CAD Burnham, ML Yarbrough, C Squires, J Fox, ... Epidemiology 45 (3), 384-386, 2024 | | 2024 |
EFFECT OF GLUCAGON-LIKE PEPTIDE 1 RECEPTOR AGONIST PHARMACOTHERAPY ON WEIGHT LOSS IN PATIENTS WITH AND WITHOUT POLYCYSTIC OVARY SYNDROME EG Gleason, L Levine, IT Lee, NC Koelper, A Amaro, A Dokras Fertility and Sterility 120 (4), e33-e34, 2023 | | 2023 |
Racial disparities in receipt of radiation and brachytherapy in cervical cancer patients and impact on survival outcomes: Do they exist in a SEER-Medicare population?(2124) E Tubridy, E Gleason, D Saris, C Brensinger, E Ko Gynecologic Oncology 176, S212, 2023 | | 2023 |
P9 Access to gynecologic oncologist specialists for patients with a new endometrial cancer diagnosis in the United States D Saris, E Gleason, E Tubridy, N Latif, S Kim, R Giuntoli, L Cory, E Ko Gynecologic Oncology 173, S12-S13, 2023 | | 2023 |
Implementation of a standardized protocol for postpartum anemia: a prospective cohort study C Lower, E Gleason, A Toda, SK Srinivas, LD Levine, M Power, RF Hamm American Journal of Obstetrics & Gynecology 228 (1), S105-S106, 2023 | | 2023 |
Experiences Using a Multidisciplinary Model for Treating Injection Drug Use Associated Infections: A Qualitative Study NS Nolan, E Gleason, LR Marks, T Habrock-Bach, SY Liang, MJ Durkin Frontiers in Psychiatry 13, 924672, 2022 | | 2022 |
Violencia obstétrica: los derechos de autonomía reproductiva, tratamiento justo y accesibilidad en el ámbito de la salud maternal en San Carlos, Salta/Obstetric Violence: the … E Gleason | | 2018 |